I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.8100
-0.0313 (-3.72%)
Mar 31, 2025, 1:39 PM EDT - Market open
I-Mab Market Cap
I-Mab has a market cap or net worth of $65.96 million as of March 31, 2025. Its market cap has decreased by -56.80% in one year.
Market Cap
65.96M
Enterprise Value
-135.02M
1-Year Change
-56.80%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $65.96M, a decrease of -52.22%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 68.51M | -1.02% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |